Orange Book product · Generic (ANDA)
HYDROCORTISONE SODIUM SUCCINATE
HYDROCORTISONE SODIUM SUCCINATE
At a glance
Feb 05, 2026
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 05, 2026
4 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCORTISONE SODIUM SUCCINATE
Strength
EQ 100MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 219856
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCORTISONE SODIUM SUCCINATE
- —SOLU-CORTEFBrand (NDA)
NDA 009866 · PHARMACIA AND UPJOHN
- 2026HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 217191 · ZYDUS PHARMS
- 2024HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 214050 · CIPLA
- 2006A-HYDROCORTGeneric (ANDA)
ANDA 040666 · HOSPIRA
- 1989A-HYDROCORTGeneric (ANDA)
ANDA 089580 · ABBOTT
- 1989A-HYDROCORTGeneric (ANDA)
ANDA 089577 · ABBOTT
- 1989A-HYDROCORTGeneric (ANDA)
ANDA 089578 · ABBOTT
- 1989A-HYDROCORTGeneric (ANDA)
ANDA 089579 · ABBOTT
- 1984HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 088670 · ABRAXIS PHARM
- 1984HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 088667 · ABRAXIS PHARM
- 1984HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 088712 · ABRAXIS PHARM
- 1984HYDROCORTISONE SODIUM SUCCINATEGeneric (ANDA)
ANDA 088668 · ABRAXIS PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
